$18.57
0.291.59%
At close: -
$18.57
0.000.00%
After Hours: 4:24 PM EDT
Comments
Loading...
ArriVent BioPharma Earnings Estimates, EPS & Revenue | NASDAQ:AVBP | Benzinga
ArriVent BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.790
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of ArriVent BioPharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVBP | ArriVent BioPharma | -$0.70 | -$0.79 | — | — | $0.00 | — | — | — | 05/07/2025 | Get Alert |
| AVBP | ArriVent BioPharma | — | -$1.10 | -$0.61 | 44.55% | — | — | $0.00 | — | 03/03/2025 | Get Alert |
| AVBP | ArriVent BioPharma | -$5.52 | -$0.82 | -$0.61 | 25.61% | $0.00 | — | $0.00 | — | 11/13/2024 | Get Alert |
| AVBP | ArriVent BioPharma | -$10.79 | -$0.54 | -$0.65 | -20.37% | $0.00 | — | $0.00 | — | 08/14/2024 | Get Alert |
| AVBP | ArriVent BioPharma | -$9.45 | -$1.05 | -$0.70 | 33.33% | $0.00 | — | $0.00 | — | 05/08/2024 | Get Alert |
ArriVent BioPharma (AVBP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $-0.61 | $-1.10 | 44.5 % |
| Q3 | 2024-11-13 | $-0.61 | $-0.82 | 25.6 % |
| Q2 | 2024-08-14 | $-0.65 | $-0.54 | -20.4 % |
| Q1 | 2024-05-08 | $-0.70 | $-1.05 | 33.3 % |
ArriVent BioPharma (AVBP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is ArriVent BioPharma (NASDAQ:AVBP) reporting earnings?
ArriVent BioPharma (AVBP) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for ArriVent BioPharma (NASDAQ:AVBP)?
The Actual EPS was $-0.61, which beat the estimate of $-1.10.
What were ArriVent BioPharma’s (NASDAQ:AVBP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.